Co-Diagnostics, Inc. — Form D
Co-Diagnostics, Inc. of SALT LAKE CITY, UT, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-14. The offering totals $47.2M, of which $46.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-01-14
- Form: D
- Accession: 0001692415-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $47.2M
- Amount sold: $46.6M
- Remaining: $604K
- Investors: 22
- Date of first sale: 2021-12-31
- Security types: equity
- Revenue range: $25,000,001 - $100,000,000
- SEC file number: 021-429617
Issuer
- Name: Co-Diagnostics, Inc.
- CIK: 0001692415
- Entity type: Corporation
- Jurisdiction: UTAH
- Incorporated: 2013
- Address: 2401 South Foothill Drive, SALT LAKE CITY, UT, 84109
- Phone: 8014821036
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Brian Brown | Executive Officer | TARZANA, CA |
| Dwight Egan | Executive Officer | Salt Lake City, UT |
| Reed L Benson | Director | Salt Lake City, UT |
| Reed L Benson | Executive Officer | Salt Lake City, UT |
| Dwight H Egan | Executive Officer | Salt Lake City, UT |
| Brent L Satterfield | Director | Salt Lake City, UT |
Other filings by this issuer (1)
More